96 related articles for article (PubMed ID: 12584559)
1. Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation.
Roccato E; Pagliardini S; Cleris L; Canevari S; Formelli F; Pierotti MA; Greco A
Oncogene; 2003 Feb; 22(6):807-18. PubMed ID: 12584559
[TBL] [Abstract][Full Text] [Related]
2. Role of the TFG N-terminus and coiled-coil domain in the transforming activity of the thyroid TRK-T3 oncogene.
Greco A; Fusetti L; Miranda C; Villa R; Zanotti S; Pagliardini S; Pierotti MA
Oncogene; 1998 Feb; 16(6):809-16. PubMed ID: 9488046
[TBL] [Abstract][Full Text] [Related]
3. Xenopus laevis TRK-fused gene (TFG) is an SH3 domain binding protein highly expressed in the cement gland.
Ohan N; Sabourin D; Booth RA; Liu XJ
Mol Reprod Dev; 2000 Jul; 56(3):336-44. PubMed ID: 10861999
[TBL] [Abstract][Full Text] [Related]
4. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
6. Analysis of SHP-1-mediated down-regulation of the TRK-T3 oncoprotein identifies Trk-fused gene (TFG) as a novel SHP-1-interacting protein.
Roccato E; Miranda C; Raho G; Pagliardini S; Pierotti MA; Greco A
J Biol Chem; 2005 Feb; 280(5):3382-9. PubMed ID: 15557341
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
Greco A; Miranda C; Pagliardini S; Fusetti L; Bongarzone I; Pierotti MA
Genes Chromosomes Cancer; 1997 Jun; 19(2):112-23. PubMed ID: 9172002
[TBL] [Abstract][Full Text] [Related]
8. Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
Greco A; Miranda C; Pierotti MA
Mol Cell Endocrinol; 2010 May; 321(1):44-9. PubMed ID: 19883730
[TBL] [Abstract][Full Text] [Related]
9. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
[TBL] [Abstract][Full Text] [Related]
10. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.
Mitra G
Oncogene; 1991 Dec; 6(12):2237-41. PubMed ID: 1837350
[TBL] [Abstract][Full Text] [Related]
12. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
Butti MG; Bongarzone I; Ferraresi G; Mondellini P; Borrello MG; Pierotti MA
Genomics; 1995 Jul; 28(1):15-24. PubMed ID: 7590742
[TBL] [Abstract][Full Text] [Related]
13. Characterization of TFG in mus musculus and Caenorhabditis elegans.
Mencinger M; Aman P
Biochem Biophys Res Commun; 1999 Apr; 257(1):67-73. PubMed ID: 10092511
[TBL] [Abstract][Full Text] [Related]
14. Characterization and chromosomal mapping of the human TFG gene involved in thyroid carcinoma.
Mencinger M; Panagopoulos I; Andreasson P; Lassen C; Mitelman F; Aman P
Genomics; 1997 May; 41(3):327-31. PubMed ID: 9169129
[TBL] [Abstract][Full Text] [Related]
15. The signaling adapters fibroblast growth factor receptor substrate 2 and 3 are activated by the thyroid TRK oncoproteins.
Ranzi V; Meakin SO; Miranda C; Mondellini P; Pierotti MA; Greco A
Endocrinology; 2003 Mar; 144(3):922-8. PubMed ID: 12586769
[TBL] [Abstract][Full Text] [Related]
16. Rearrangements of NTRK1 oncogene in papillary thyroid carcinoma.
Brzeziańska E; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Jun; 28(3):221-9. PubMed ID: 17627253
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic rearrangements of the NTRK1/NGF receptor.
Pierotti MA; Greco A
Cancer Lett; 2006 Jan; 232(1):90-8. PubMed ID: 16242838
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.
Greco A; Mariani C; Miranda C; Pagliardini S; Pierotti MA
Genomics; 1993 Nov; 18(2):397-400. PubMed ID: 8288244
[TBL] [Abstract][Full Text] [Related]
19. The TFG protein, involved in oncogenic rearrangements, interacts with TANK and NEMO, two proteins involved in the NF-kappaB pathway.
Miranda C; Roccato E; Raho G; Pagliardini S; Pierotti MA; Greco A
J Cell Physiol; 2006 Jul; 208(1):154-60. PubMed ID: 16547966
[TBL] [Abstract][Full Text] [Related]
20. Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc.
Roccato E; Miranda C; Ranzi V; Gishizki M; Pierotti MA; Greco A
Br J Cancer; 2002 Sep; 87(6):645-53. PubMed ID: 12237775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
